The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding
AUTOR(ES)
Prota, Andrea E.
FONTE
National Academy of Sciences
RESUMO
Human complement receptor type 2 (CD21) is the cellular receptor for Epstein–Barr virus (EBV), a human tumor virus. The N-terminal two short consensus repeats (SCR1–SCR2) of the receptor interact with the EBV glycoprotein gp350/220 and also with the natural CD21 ligand C3d. Here we present the crystal structure of the CD21 SCR1–SCR2 fragment in the absence of ligand and demonstrate that it is able to bind EBV. Based on a functional analysis of wild-type and mutant CD21 and molecular modeling, we identify a likely region for EBV attachment and demonstrate that this region is not involved in the interaction with C3d. A comparison with the previously determined structure of CD21 SCR1–SCR2 in complex with C3d shows that, in both cases, CD21 assumes compact V-shaped conformations. However, our analysis reveals a surprising degree of flexibility at the SCR1–SCR2 interface, suggesting interactions between the two domains are not specific. We present evidence that the V-shaped conformation is induced by deglycosylation of the protein, and that physiologic glycosylation of CD21 would result in a more extended conformation, perhaps with additional epitopes for C3d binding.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=124999Documentos Relacionados
- Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
- Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).
- gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.
- Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
- Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.